Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment

Universidad Autonoma de Nuevo Leon

Status and phase: Completed; Phase 2

Conditions: Bursitis

Treatments: Drug: EXPERIMENTAL; Drug: PLACEBO

Study type: Interventional

Funder types: Other

Identifiers

NCT01205477

RE09-009

Details and patient eligibility

About

To investigate the safety and efficacy of methylprednisolone infiltration in anserine bursitis treatment

Enrollment: 58 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of anserine bursitis

Exclusion criteria

• Intraarticular pathology that reflects pain in the medial part of the knee

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

58 participants in 2 patient groups, including a placebo group

Methylprednisolone

Experimental group

Description:

Infiltration of 40 mg of methylprednisolone acetate plus 1 mL of xylocaine

Treatment:

Drug: EXPERIMENTAL

Placebo

Placebo Comparator group

Description:

Infiltration of 1 mL of xylocaine

Treatment:

Drug: PLACEBO